On 23rd June 2016, the UK voted to leave the European Union. Over the next couple of years, the Government will need to work out what our new relationship with the EU looks like, including for UK research. For us, there are three key areas that we would like to see prioritised to ensure that cardiovascular research continues to thrive once the UK has left the EU:
• Lots of researchers in the UK receive EU funding to support their vital work – we’d like to ensure that UK researchers maintain the ability to apply for EU research funding and that overall investment in UK science does not decrease from the current level.
• Science is international and hugely collaborative – we’d like to see ease of movement between the UK and the EU maintained for researchers and relevant skilled professionals to ensure that researchers can continue to collaborate freely.
• From rules around clinical trials to data access, several aspects of research are currently subject to EU law – it is important that the UK research community is consulted and involved in discussions on the future of research regulation and the licensing of new medicines.
We’ll be working hard to highlight these and promote the interests of UK research as these negotiations begin.
Want to find out more? Our Chief Executive has recently given his perspective on how to ensure UK medical research excellence after Brexit.